'Designer Babies': The Ultimate Privileged Elite?
By Heather Long,
Guardian
| 07. 09. 2013
When the world looks back at how the "designer babies" trend began, they will see an innocent start.
A Philadelphia couple who had gone through the physical and emotional marathon of trying to have a child turned to intra-uterine insemination and ultimately IVF. Like any rational people, they wanted to do everything to increase their chances that IVF would work. In this case, they sent the embryos to an Oxford lab, which ran a kind of
minimal DNA test to see which embryos would be most likely to take.
It's hard to deny this Philadelphia couple the chance to be parents. David Levy and Marybeth Scheidts look very wholesome in their family photo holding their son Connor, born in May 2013. They clearly weren't trying to select the embryo with their preferred hair or eye color or other physical or mental traits. In fact, they didn't even have a full DNA analysis done, only a scan of the chromosomes, the structures that hold genes. This isn't Brave New World-esque test tube babies. It's a traditional family – with the best...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...